Suivant

Feedback on schizophrenia treatment has been great, says Bristol Myers Squibb CEO

14/01/25
CNBC Télévision

Bristol Myers Squibb CEO Christopher Boerner joins 'Mad Money' host Jim Cramer to talk its new schizophrenia treatment Cobenfy, its oncology business, and more.

Montre plus

 0 commentaires sort   Trier par


Suivant